medigraphic.com
ISSN 1561-297X (Print)

2013, Number 2

<< Back Next >>

Rev Cubana Estomatol 2013; 50 (2)

Combined effect of Cinnamomum zeylanicum blume essential oil and nystatin on strains of non-albicans Candida

Dias CR, Leite CA, de Oliveira LE

Language: English
References: 34
Page:
PDF size: 57.17 Kb.


ABSTRACT

Introduction: considering the emergence of resistant species of albicans and non-albicans Candida to agents therapeutically available as a result of the increased number of immunocompromised population and of the increasingly frequent use of prophylaxis and empirical treatment with antifungals, it's verified that there is a clear and emerging need to introduce new antimicrobials agents in the therapeutic arsenal. The purpose of this study was to evaluate the antifungal activity of essential oil of Cinnamomum zeylanicum Blume alone and combined with Nystatin on strains of C. tropicalis and C. krusei.
Methods: this was an experimental research in laboratory. It was determined the Minimum Inhibitory Concentration, using the microdilution method, as well as the Fractional Inhibitory Concentration to determine the possible synergistic effects of the association. Strains of C. tropicalis ATCC 40147 and C. krusei ATCC 40042 were used in the tests. When assessed separately, C. zeylanicum essential oil and Nystatin presented Minimum Inhibitory Concentration of 312,5 µg/mL and 64 µg/mL, respectively, on both tested strains.
Results: When combined, were found Minimum Inhibitory Concentration of 39 µg/mL and 32 µg/mL for the essential oil and for Nystatin, respectively. The Fractional Inhibitory Concentration value was 0,6024 for both tested strains, indicating additivity of the inhibitory effect on fungal growth.
Conclusions: the results indicate that C. zeylanicum essential oil has antifungal activity against the strains of non-albicans Candida evaluated and that its association with Nystatin potentiates this effect.


REFERENCES

  1. Erdem F, Tuncer Ertem G, Oral B, Karakoç E, Demiröz AP, Tülek N. Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species. Mikrobivol Bul. 2012;6:637-48.

  2. Harriott MM, Noverr MC. Importance of Candida-bacterial polymicrobial biofilms in disease. Trends Microbiol. 2011;19:557-63.

  3. Pellizzaro D, Polyzois G, Machado AL, Giampaolo ET, Sanitá PV, Vergani CE. Effectiveness of mechanical brushing with different denture cleaning agents in reducing in vitro Candida albicans biofilm viability. Braz Dent J. 2012;23:547-54.

  4. Anwar KP, Malik A, Subhan KH. Profile of candidiasis in HIV infected patients. Iran J Microbiol. 2012;4:204-9.

  5. De Luca C, Guglielminetti M, Ferrario A, Calabr M, Casari E. Candidemia: species involved, virulence factors and antimycotic susceptibility. New Microbiol. 2012;35:459- 68.

  6. Cleary IA, Reinhard SM, Miller CL, Murdoch C, Thornhill MH, Lazzell AL, Monteagudo C, Thomas DP, Saville SP. Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis. Microbol. 2011;157:1806-15.

  7. Mwangosi IE, Tillya J. Oral lesions associated with HIV/AIDS in HIV-seropositive patients attending a counselling and treatment centre in Dar es Salaam. Int Dent J. 2012;62:197-202.

  8. Scalercio M, Valente T, Israel MS, Ramos ME. Denture stomatitis associated with candidiasis: diagnosis and treatment. RGO. 2007;55(4):395-8.

  9. Shreaz S, Bhatia R, Khan N, Maurya IK, Ahmad SI, Muralidhar S, Manzoor N, Khan LA. Cinnamic aldehydes affect hydrolytic enzyme secretion and morphogenesis in oral Candida isolates. Microb Pathog. 2012;52:251-8.

  10. Katiraee F, Khosravi AR, Khalaj V, Hajiabdolbaghi M, Khaksar A, Rasoolineiad M, Yekaninejad MS. Oropharyngeal candidiasis and oral yeast colonization in Iranian Human Immunodeficiency Virus positive patients. J Med Mycol. 2012;20(1):8-14.

  11. Paiva LCA, Ribeiro RA, Pereira JV, Oliveira NMC. Avaliaçăo clínica e laboratorial do gel da Uncaria tomentosa (Unha de Gato) sobre candidose oral. Rev Brás farmacogn [online].2009[cited 2013-03-07];19(2a):423-28. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102- 695X2009000300015&lng=en&nrm=iso

  12. Bicmen C, Doluca M, Gulat S, Gunduz AT, Tuksavul F. Species level identification and antifungal susceptibility of yeast isolated from various clinical specimens and evaluation of Integral System Yeasts Plus. New Microbiol. 2012; 35:327-34.

  13. Khan R, Islam B, Akram M, Shakil S, Ahmad AA, Ali SM, Siddiqui M, Khan AU. Antimicrobial activity of five herbal extracts against multi drug resistant (MRD) strains of bacteria and fungus of clinical origin. Molecules. 2009;14:586-97.

  14. Pozzatti P, Scheid IA, Spader TB, Atayde ML, Santurio JM, Alves SH. In vitro activity of essential oils extracted from plants used as spices against fluconazoleresistant and fluconazole-susceptible Candidaspp. Can J Microbiol. 2008;54:950-60.

  15. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.

  16. Estrella-cuenca M. Combinations of antifungal agents in therapywhat value are they? J Antimicrob Chemother. 2004;54:854-69.

  17. Puangpronpitag D, Sittiwet C. Antimicrobial properties of Cinnamomum verum aqueous extract. Asian J Biological Sci. 2009;2:49-53.

  18. Bansod S, Rai M. Antifungal activity of essential oils from Indian medicinal plants against human pathogenic Aspergillus fumigates and A. niger. W J Med Sci. 2008;3:81-8.

  19. Ellof JN. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica. 1998;64:711-3.

  20. Deswal DP, Chand U. Standartization of the tetrazolium test for viability estimation in ricebean (Vigna umbellate T.) seeds. Seed Science and Technology. 1997;25:409- 17.

  21. Dutta NK, Dastidar SG, Kumar A, Mazumdar K, Ray R, Chakrabarty NA. Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin. Braz J Microbiol. 2004;35:316-23.

  22. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V. Antibiotics in Laboratory Medicine. Baltimore: Williams and Wilkins;1991:434-44.

  23. Nightingale CH, Ambrose PG, Drusano GI, Murakawa T. Antimicrobial Pharmacodynamics in Theory and Cinical Practice. 2. ed. New York: Informa healthcare; 2007. p. 516.

  24. Schmidt E, Jirovetz l, Wlcek K, Buchbauer G, Gochev V, Girova T, Stoyanova A, Geissler M. Antifungal activity of eugenol and various eugenol-containing essential oils against 38 clinical isolates of Candida albicans. J Essent Oil Bearing Plants. 2007;10:421-29.

  25. Carvalhinto S, Costa AM, Coelho AC, Martins E, Sampaio A. Susceptibilities of Candida albicans mouth isolates to antifungal agents, Essentials oils and mouth rinses. Mycopathol. 2012;174:69-76.

  26. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10-24.

  27. Quale JM, Landman D, Zaman M, Bumey S, Sathe SS. In Vitro Activity of Cinnamomum zeylanicumAgainst Azole Resistant and Sensitive Candida Species and a Pilot Study of Cinnamon for Oral Candidiasis. Am J Chin Med. 1996;24:103-9.

  28. Meades GJR, Henken RL, Waldrop GL, Rahman MM, Gilman SD, Kamatou GP, Viljoen AM, Gibbons S. Constituents of Cinnamon Inhibit Bacterial Acetyl CoA Carboxylase. Planta Medica 2010; 76:1570-75.

  29. Gamarra S, Rocha EMF, Zhang YQ, Park S, Rao R, Perlin DS. Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans. Antimicrob Agents Chemother. 2010;54:1753-1761.

  30. Zhai B, Zhou H, Yang I, Zhang J, Jung K, Giam C, Xiang X, Lin X. Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect. J Antimicrob Chemother. 2010;65:931-8.

  31. Coutinho HD, Costa JG, Lima EO, Falcăo-Silva VS, Siqueira-Júnior JP. In vitro interference of Hyptis martiusii Benth and chlorpromazine against an aminoglycoside-resistant Escherichia coli. Indian J Med Res. 2009;129:566568.

  32. Coutinho HD, Costa JG, Lima EO, Falcăo-Silva VS, Siqueira-Júnior JP. Potentiating effect of Mentha arvensis and chlorpromazine in the resistance to aminoglycosides of methicillin-resistant Staphylococcus aureus. In Vivo. 2009;23:287-9.

  33. Johnson MD, Macdougall C, Ostrosky-Zeichner I, l.; perfect, j. R.; Rex, j. H. Combination Antifungal Therapy. J Antimicrob Chemother 2004; 3:693-715.

  34. Zago JAA, Ushimaru PI, Barbosa IN, Fernandes Júnior A. Synergism between essential oils antimicrobial drugs against Staphylococcus aureus and Escherichia coli strains from human infections.Braz J Pharmacogn. 2009;19:828-33.




2020     |     www.medigraphic.com